Vera Ignjatović: Why Is Thrombosis Research So Far Behind When It Comes to AI and Multi-Omics?
Vera Ignjatović, Founder and Managing Director at Ignis Innovations Pty Ltd, Principal Consultant of Translational Research at Johns Hopkins All Children’s Hospital, shared on LinkedIn about a recent article she and her colleagues co-authored, published in RPTH Journal, adding:
”I am excited to share a paper co-authored with my colleagues Steven Bruzek, MS, MB(ASCP), Grant Vestal, and Neil Goldenberg, MD PhD just published in RPTH Journal that asks a question our field (thrombosis) really needs to sit with.
Why is thrombosis research so far behind when it comes to AI and multi-omics?
Our paper focuses on:
- Multi-omics (genomics, proteomics, metabolomics, etc.) is already transforming cancer and cardiovascular research.
- AI helps researchers make sense of massive, complex datasets that would otherwise be difficult to analyze.
- But in thrombosis research? Only FOUR studies have ever used AI with multi-omics.
That gap represents a problem, but also a great opportunity!
Blood clots kill.
Deep vein thrombosis, pulmonary embolism, and stroke are not rare events, particularly not in adults, and hospitalized children.
We have the tools to better predict, diagnose, and treat blood clots.
We are simply not (yet) using them broadly in this field.
In this paper, we are calling on the thrombosis community to step up.
Specifically, more collaboration, more training, more data sharing, and more investment in the next generation of researchers who can bridge the gap between biology and data science.
I am genuinely passionate about this space.”
Title: Artificial Intelligence (AI)-Empowered, Clinically-Integrated Multi-Omics Research in Thrombosis: A Call to Action
Authors: Steven Bruzek, Grant Vestal, Neil Goldenberg, Vera Ignjatovic
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering